Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in rats

被引：22
作者：
Segal, Lawrence [1 ]
Wilby, Owen K. [2 ]
Willoughby, Chris R. [2 ]
Veenstra, Stephane [1 ]
Deschamps, Marguerite [1 ]
机构：
[1] GlaxoSmithKline Biol, B-1300 Rixensart, Belgium
[2] Huntingdon Life Sci, Eye IP23 7PX, Suffolk, England
来源：
REPRODUCTIVE TOXICOLOGY | 2011年 / 31卷 / 01期
关键词：
Cervarix (TM); AS04; HPV; Vaccine; Fertility; Development; MPL; VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; YOUNG-WOMEN; LIPID-A; IMMUNIZATION; EFFICACY; PREVENTION; INFECTION; INFANTS;
D O I：
10.1016/j.reprotox.2010.09.001
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Cervarix (TM) is a prophylactic human papillomavirus (HPV)-16/18 vaccine for the prevention of cervical cancer. It contains GSK Biologicals' proprietary Adjuvant System AS04. The objective of this study was to investigate the effects of Cervarix (TM) and of AS04 on female fertility and pre- and post-natal development in Sprague Dawley rats. Female rats were injected with vaccine, AS04, or saline 30 days before mating and on Gestation Days 6, 8, 11 and 15. Each dose of vaccine was one-fifth the human dose volume. Treatment of rats with vaccine or AS04 was not associated with any systemic toxicity and had no impact on female fertility. There were no adverse effects on pre- or post-natal development of litters from treated rats, as judged by fetal evaluation at Gestation Day 20, and growth and survival of pups to postnatal Day 25. These results support the use of the vaccine in the targeted human population. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：111 / 120
页数：10
相关论文
共 37 条
  • [1] Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
    Baldridge, JR
    McGowan, P
    Evans, JT
    Cluff, C
    Mossman, S
    Johnson, D
    Persing, D
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) : 1129 - 1138
  • [2] IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION
    BREITBURD, F
    KIRNBAUER, R
    HUBBERT, NL
    NONNENMACHER, B
    TRINDINHDESMARQUET, C
    ORTH, G
    SCHILLER, JT
    LOWY, DR
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3959 - 3963
  • [3] CARLSON BM, 1999, HUMAN EMBRYOLOGY DEV, P420
  • [4] Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
    Casella, C. R.
    Mitchell, T. C.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) : 3231 - 3240
  • [5] Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
    Christensen, ND
    Reed, CA
    Cladel, NM
    Han, R
    Kreider, JW
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 960 - 965
  • [6] A note on the staining of the skeleton of cleared - Specimens with alizarin red S
    Dawson, AB
    [J]. STAIN TECHNOLOGY, 1926, 1 (04): : 123 - 124
  • [7] Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention A pooled analysis of 11 clinical trials
    Descamps, Dominique
    Hardt, Karin
    Spiessens, Bart
    Izurieta, Patricia
    Verstraeten, Thomas
    Breuer, Thomas
    Dubin, Gary
    [J]. HUMAN VACCINES, 2009, 5 (05): : 332 - 340
  • [8] Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and-18 cervical cancer vaccine
    Deschuyteneer, Michel
    Elouahabi, Abdelatif
    Plainchamp, Dominique
    Plisnier, Michel
    Soete, Dominique
    Corazza, Yvon
    Lockman, Laurence
    Giannini, Sandra
    Deschamps, Marguerite
    [J]. HUMAN VACCINES, 2010, 6 (05): : 407 - 419
  • [9] AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
    Didierlaurent, Arnaud M.
    Morel, Sandra
    Lockman, Laurence
    Giannini, Sandra L.
    Bisteau, Michel
    Carlsen, Harald
    Kielland, Anders
    Vosters, Olivier
    Vanderheyde, Nathalie
    Schiavetti, Francesca
    Larocque, Daniel
    Van Mechelen, Marcelle
    Garcon, Nathalie
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (10) : 6186 - 6197
  • [10] A good practice guide to the administration of substances and removal of blood, including routes and volumes
    Diehl, KH
    Hull, R
    Morton, D
    Pfister, R
    Rabemampianina, Y
    Smith, D
    Vidal, JM
    van de Vorstenbosch, C
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 (01) : 15 - 23
1234